CN
99-96-7
应用筛选条件
关键词:'99-96-7'
显示 1-30 共 876 条结果 关于 "99-96-7" 范围 技术文档
Brochure: Milli-Q® SQ 2Series - Chinese
在整个产品生命周期内，按7年计算设备和耗材质量。
3 增加一个超纯水分配系统，总质量会随之增加。
4 每个取水点由一个Milli-Q® SQ 200 超纯水分配系统和一个Milli-Q® SQ Switch 水箱组成。
14
水质合规性
Milli-Q® SQ 2系列 的纯水系统用于生产RO纯水：
• 离子含量截留率通常 > 96%
• 有机物和微粒截留率通常 > 99%
Milli-Q
Albumin Application Selection Guide
A6003 A3059 A7638 B9543 A9430 A7888 B4287 B2518
Purity (%) 96-99% 96-99% >96% ~99% >99% >98% >98% 96-99% >98% >98%
pH 5.2 7 7 7 7 7 7 5.2 7 7
Characteristics
Standard
Grade
Standard
Grade
Fatty-acid
The Effective Use of Protein Kinase Inhibitors
89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79
The Effective Use of Protein Kinase Inhibitors
89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79
Product Information Sheet - A8551
IgG/mg by HPLC)
A6003 Charcoal $96% Starting material: A-4503 Powder ~5.2
Essentially fatty acid free
(-0.005%)
A3059 Heat treatment -99% Protease free Powder ~7
(#0.001 protease units/mg)
Essentially
Product Information Sheet - A9511
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A6909
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A3173
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A8763
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A1653
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A6784
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A2817
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A4327
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A1887
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A9080
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A3782
CHARACTERISTICS
A 1653 Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817 Fraction V1 Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
MultiScreen Assay System for High Throughput Cell-based Transport
Caco-2 Company B
Ap ➞ BL Assay System 96-well Plate
Ratio 10 day 21 day 10 day 21 day
Digoxin 11.5 30.5 6.6 14.5
% LY rejection AP/BL 99 >99
Measuring Immune Response and Cytokine Autoantibodies in Human Sepsis Samples
5.94 95
IL-5 0.64-10,000 0.17 3.99 5.42 99
IL-6 0.64-10,000 0.14 5.06 6.13 96
IL-7 0.64-10,000 0.14 4.85 4.61 97
IL-8 0.64-10,000 0.52 3.07 5.05 96
IL-9 0.64-10,000 2.82 3.47 5.13 101
Natural Lineage Markers
) Anti-SCGN calcium binding protein ENSG00000079689 IHC 96 / 96%
HPA023099 Anti-CALB1 (CB) calcium binding protein ENSG00000104327 IHC,WB 98 / 99%
HPA007305 Anti-CALB2 (CR) calcium binding protein ENSG00000172137
Verfication summary-03-0202-00
3 150.0 159.29 6.0 4% 104%
3 75.0 77.53 5.0 6% 99%
3 37.5 40.69 0.8 2% 100%
HMN108012
2 0.0
50
1.37 0.0 0% -
3 150.0 150.42 10.3 7% 99%
Verfication summary-03-0202-00
3 150.0 159.29 6.0 4% 104%
3 75.0 77.53 5.0 6% 99%
3 37.5 40.69 0.8 2% 100%
HMN108012
2 0.0
50
1.37 0.0 0% -
3 150.0 150.42 10.3 7% 99%
Product Information Sheet - A5394
259 7
15.4
Novabiochem Innovations 03/10
days
COMU 96 47 14
COMU (dried) 98 58 16
HDMC 99 98 93
HATU 99 98 97
HBTU 99 99 99
HCTU 99 99 98
TOTU 98 72 42
PyBOP 99 73 34
PyOxim 99 82 47
Ezracom 98 86 59
Coupling reagent 2 days 7
Product Information Sheet - A3147
Wavelength pH
15.4 259 7
GenElute-E Single SpinPlant DNA 96 Kit
µL of the
Bead-Beating Master Mix per well of Tube Strips.
Number of samples 1 96 (+20%)
Bead-Beating Buffer 99 µL 11,404.8 µL
RNase A Plant 1 µL 115.2 µL
Final Volume 100 µL 11,520
Quick start Guide- EC596
µL of the
Bead-Beating Master Mix per well of Tube Strips.
Number of samples 1 96 (+20%)
Bead-Beating Buffer 99 µL 11,404.8 µL
RNase A Plant 1 µL 115.2 µL
Final Volume 100 µL 11,520
Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel
pg/mL IL-9 Control 1 96 - 199 pg/mL
Control 2 507 - 1054 pg/mL Control 2 601 - 1247 pg/mL Control 2 475 - 986 pg/mL
IL-5 Control 1 89
Testing Lab & Industrial Flyer
for environmental analysis
1527-96-4 Analytical, Environmental, Standard
C6158 Crystal Violet ACS reagent, ≥90.0% anhydrous basis — Indicator
410217 2′,7′-Dichlorofluorescein ACS reagent 76-54
Polymer Products Applicaton & Reference Information
40,807-7 (Cumene)cyclopentadienyliron(II)
hexafluorophosphate, 98%
D3,173-7 Dibenzosuberenone, 97%
22,710-2 2,2-Diethoxyacetophenone, 95%
D11,050-7 4,4'-Dihydroxybenzophenone, 99%
Cat.
1/30